AGENDA
FRIDAY March 18, 2011
7:00 Registration
Continental Breakfast
8:00 Welcome & Objectives
Keye Wong, M.D.
8:00 Nature and Nurture are Related to Macular Degeneration
Johanna Seddon, M.D.
8:30 Genetics for Dummies: Helping Practicing Ophthalmologists Interpret the
Literature
Karen Gehrs, M.D.
9:00 Can Gene Therapy Improve Current Management of AMD?
Szilárd Kiss, M.D.
9:30 Prediction Models for Macular Degeneration
Johanna Seddon, M.D.
10:00 Break
10:30 What’s New or About to be New in AMD Therapy?
Michael Tolentino, M.D.
11:00 Do Intraocular Anti-VEGF Injections Harm the Optic Nerve?
David Browning, M.D.
11:30 Does “Treat and Extend” Increase the Risk of “Massive” Subretinal
Hemorrhage?
John Niffenegger, M.D.
12:00 Lunch
1:00 Pearls and Pitfalls in Interpreting Spectral Domain OCT
Glenn Jaffe, M.D.
1:30 New Screening Guidelines for Plaquenil Toxicity
David Browning, M.D.
2:00 Imaging the Retina with Adaptive Optics
Szilárd Kiss, M.D.
2:30 ROP Management in the Era of Anti-VEGF Therapy and Thrombogenics
Michael Trese, M.D.
3:00 Uveitis: Update on Steroid Implants
Glenn Jaffe, M.D.
3:30 Adjourn
4:00 Exhibit Hall Reception
SATURDAY March 19, 2011
7:00 Continental Breakfast
8:00 Management of Dislocated IOL’s
Kirk Packo, M.D.
8:30 Endopohthalmitis: Prevention & Current Management
Harry Flynn, M.D.
9:00 Enzymatic Vitreolysis – The Current and Future Use of Microplasmin
Enzyme
Michael Trese, M.D.
9:30 Macular Hole Surgery: Have Newer Techniques Improved Outcomes?
Harry Flynn, M.D.
10:00 Break
10:30 Retinal Complications of Refractive Surgery
Kirk Packo, M.D.
11:00 Is Our Traditional Management of Diabetic Retinopathy Evidenced-Based?
Keye Wong, M.D. / Panel
11:30 Do Current Clinical Trials Alter Traditional Management of Diabetic
Retinopathy?
David Browning, M.D. / Panel
12:00 Management of Retinal Vein Occlusions: Is There a New Standard of Care?
Michael Tolentino, M.D.
12:30 Lunch
1:30 How to Manage Retina Injectables Without Losing Your Shirt
Richard Hamilton, M.D. / Panel
2:00 The Art of Patient Satisfaction in Retinal Patients
Kirk Packo, M.D.
2:30 Risk Management of the Retina Patient
Arthur Allen, M.D.
3:30 Adjourn
*Program subject to change
Ophthalmology
A Retina Symposium designedspecifically for the
Ophthalmologic community.
Lippincott CME Institute, Inc. designates this live activity for a maximum of 11.5 AMA PRA Category I Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
LEARNING OBJECTIVES
After completing this course participants
should be better able to:
- Develop strategies to incorporate new technology to diagnose posterior segment disease.
- Interpret emerging data on new treatment options in retinal disease
- Evaluate how to incorporate these data into practice
Sarasota, FL (October 26, 2010) – Retina Associates of Sarasota, The Center for Retina and Macular Disease, and Lippincott CME Institute
are proud to jointly sponsor The Florida Retina Symposium Sarasota.
10.26.10
Story
Link
Orlando, FL (December 5, 2009) – Retina Associates of Sarasota, The Center for Retina and
Macular Disease, and Lippincott CME Institute are proud to jointly sponsor The Florida Retina
Symposium at Walt Disney World.
12.05.09
Story
Link
Orlando, FL (October 5, 2009) - For the third consecutive year, The Center for Retina and Macular Disease produced a high quality educational event specifically for the optometric community. 10.05.09
Story
Link
WINTER HAVEN, FL - The faculty and staff at CRMD is once again extremely proud to
announce the 3rd Annual Florida Retina Symposium. 06.04.09
Story
Link
Two exclusive advances in diagnostic capabilities: Ultra Wide Field Angiography
and Ultra High-Resolution Spectral Domain Optical Coherence Tomography (OCT) announced Monday. 10.28.08
Story Link
| Follow us on: | |
 |
 |